Tissue Homogenate VEGF Levels in Malignant Salivary Gland Tumors vs. Controls: An Exploratory Pilot Study

Area of Science:

• Oncology
• Molecular Biology
• Pathology

Background:

• Salivary gland tumors are rare, heterogeneous, and pose diagnostic/treatment challenges.
• Angiogenesis, driven by vascular endothelial growth factor (VEGF), is crucial in tumor progression.
• Understanding VEGF's role in salivary gland tumors is vital for potential therapeutic targets.

Purpose of the Study:

• To compare vascular endothelial growth factor (VEGF) levels in salivary gland tumor tissue versus normal salivary gland tissue.
• To investigate the feasibility of VEGF quantification in salivary gland tissue homogenates.

Main Methods:

• Tissue samples from 13 patients (9 with malignant lesions, 4 controls) were analyzed.
• VEGF concentration was measured using a chemiluminescent ELISA kit.
• Statistical analysis included Mann-Whitney U test and Welch's t-test.

Main Results:

• VEGF concentrations were higher in tumor tissue compared to normal tissue, but this difference lacked statistical significance (p=0.199).
• Significant inter-individual variability in VEGF levels was observed, with overlap between tumor and control groups.
• The quantification method proved feasible, despite high variability.

Conclusions:

• VEGF quantification in salivary gland tissue is feasible but shows high variability.
• While a trend for higher VEGF in tumors was noted, it did not reach statistical significance in this small cohort.
• Findings are hypothesis-generating and do not currently support diagnostic or prognostic claims for VEGF in salivary gland tumors.